Skip to main content

$1 Million Risperdal Verdict Overturned

$1 Million Risperdal Verdict Overturned

$1 Million Risperdal Verdict Overturned

Introduction

In the September 21 order issued by Chief Judge Glenn T. Suddaby for the Northern District of New York, a $1 million Risperdal verdict was overturned indicating that the failure-to-warn claim made by a man against Janssen Pharmaceuticals stays preempted since the federal law bars the company from adding a gynecomastia warning label. The federal judge also stated that the ruling was passed considering the plaintiff's attorney's "inappropriate conduct" evident from his defensive tone of voice during the court hearing.

Risperdal is an antipsychotic drug prescribed to treat adult and adolescent schizophrenia, bipolar disorder, and irritability in children with autistic disorder. Plaintiffs who have filed Risperdal lawsuits claim Janssen was aware of the possible risks of the drug to cause excessive breast growth in men and boys. But intentionally ignored to warn doctors and patients about the side-effect. Two Risperdal lawsuits have been selected for punitive damages trial in Pennsylvania. The first plaintiff was awarded $1.75 million while the second was awarded $500,000 in compensatory damages. More than 6,700 similar claims are pending against Risperdal makers in the Philadelphia Court of Common Pleas. Two coordinated actions have been filed for Risperdal cases: one in Los Angeles Superior Court (Risperdal and Invega Product Liability Cases, JCCP 4775) and the other in Philadelphia (In Re: Risperdal Litigation, March 2010 Term, No. 100300296).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.